Tag Archives: U.S. FDA
FDA) has issued Establishment Inspection Report (EIR) to subsidiary Aurolife Pharma’s plant in North
Aurobindo Pharma on Monday (August 17, 2026) said the U.S. Food and Drug Administration (U.S. [...]
18
Aug
Aug
